Abstract：
UNASSIGNED: Post-stroke shoulder pain (PSSP) is a common complication that limits the range of motion (ROM) of the shoulder, the patient\'s rehabilitation and in turn, affects the patients\' quality of life (QOL). Several treatment modalities such as sling, positioning, strapping, functional electrical stimulation (FES), and nerve block have been suggested in literatures, however none of the treatments had long-term effects for PSSP. In this study, the authors evaluated clinical efficacy of pulsed radiofrequency (PRF) neuromodulation on the suprascapular nerve for PSSP, and suggested it as a potential treatment with long-term effect.
UNASSIGNED: This retrospective case series was conducted at a single center, a private practice institution. From 2013 to 2021, 13 patients with PSSP underwent PRF neuromodulation of the suprascapular nerve. The primary outcome measure was the visual analog scale (VAS) score. The secondary outcome measurements included the shoulder ROM, disability assessment scale (DAS), modified Ashworth scale (mAS), modified Rankin scale (mRS), and EuroQol-5 dimension-3L questionnaire (EQ-5D-3L) scores. These parameters were evaluated before PRF modulation, immediately after PRF modulation, and every three months until the final follow-up visit.
UNASSIGNED: Six men and seven women were enrolled, and all patients were followed-up for a minimum of 12 months. The mean VAS score was 7.07 points before PRF neuromodulation and 2.38 points immediately post-procedure. Shoulder ROM for abduction and flexion, DAS for pain, mRS, and EQ-5D-3L demonstrated marked improvement. No complications were reported.
UNASSIGNED: PRF neuromodulation of the suprascapular nerve is an effective modality in patients with PSSP, and has long-term effect of pain relief, improvement of QOL.
UNASSIGNED: This retrospective case series was conducted at a single center, a private practice institution. From 2013 to 2021, 13 patients with PSSP underwent PRF neuromodulation of the suprascapular nerve. The primary outcome measure was the visual analog scale (VAS) score. The secondary outcome measurements included the shoulder ROM, disability assessment scale (DAS), modified Ashworth scale (mAS), modified Rankin scale (mRS), and EuroQol-5 dimension-3L questionnaire (EQ-5D-3L) scores. These parameters were evaluated before PRF modulation, immediately after PRF modulation, and every three months until the final follow-up visit.
UNASSIGNED: Six men and seven women were enrolled, and all patients were followed-up for a minimum of 12 months. The mean VAS score was 7.07 points before PRF neuromodulation and 2.38 points immediately post-procedure. Shoulder ROM for abduction and flexion, DAS for pain, mRS, and EQ-5D-3L demonstrated marked improvement. No complications were reported.
UNASSIGNED: PRF neuromodulation of the suprascapular nerve is an effective modality in patients with PSSP, and has long-term effect of pain relief, improvement of QOL.
摘要：
■中风后肩痛（PSSP）是一种常见的并发症，会限制肩膀的活动范围（ROM），病人的康复，反过来，影响患者的生活质量（QOL）。几种治疗方式，如吊索，定位,捆扎,功能性电刺激（FES），和神经阻滞已经在文献中提出，然而，没有一种治疗对PSSP有长期影响。在这项研究中,作者评估了脉冲射频（PRF）神经调制对PSSP的临床疗效，并建议将其作为具有长期效果的潜在治疗方法。
■这个回顾性病例系列是在一个中心进行的，私人执业机构。从2013年到2021年，13例PSSP患者接受了肩胛骨上神经的PRF神经调节。主要结果指标是视觉模拟量表（VAS）评分。次要结果测量包括肩部ROM，残疾评估量表(DAS)，改良的Ashworth量表(MAS)，改良的Rankin量表（MRS），和EuroQol-5维度-3L问卷(EQ-5D-3L)得分。在PRF调制之前评估这些参数，在PRF调制后立即，每三个月一次，直到最后一次随访。
■注册了6名男性和7名女性，所有患者随访至少12个月.PRF神经调节前的平均VAS评分为7.07分，术后立即为2.38分。用于外展和屈曲的肩部ROM，疼痛的DAS，mRS,和EQ-5D-3L表现出显著的改善。无并发症报告。
■肩胛骨上神经的PRF神经调节是PSSP患者的有效方法，并具有缓解疼痛的长期效果，改善QOL。
■这个回顾性病例系列是在一个中心进行的，私人执业机构。从2013年到2021年，13例PSSP患者接受了肩胛骨上神经的PRF神经调节。主要结果指标是视觉模拟量表（VAS）评分。次要结果测量包括肩部ROM，残疾评估量表(DAS)，改良的Ashworth量表(MAS)，改良的Rankin量表（MRS），和EuroQol-5维度-3L问卷(EQ-5D-3L)得分。在PRF调制之前评估这些参数，在PRF调制后立即，每三个月一次，直到最后一次随访。
■注册了6名男性和7名女性，所有患者随访至少12个月.PRF神经调节前的平均VAS评分为7.07分，术后立即为2.38分。用于外展和屈曲的肩部ROM，疼痛的DAS，mRS,和EQ-5D-3L表现出显著的改善。无并发症报告。
■肩胛骨上神经的PRF神经调节是PSSP患者的有效方法，并具有缓解疼痛的长期效果，改善QOL。
